487 related articles for article (PubMed ID: 16627931)
1. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
[TBL] [Abstract][Full Text] [Related]
2. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
de la Monte SM; Tong M; Schiano I; Didsbury J
J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.
de la Monte SM; Tong M; Lester-Coll N; Plater M; Wands JR
J Alzheimers Dis; 2006 Sep; 10(1):89-109. PubMed ID: 16988486
[TBL] [Abstract][Full Text] [Related]
4. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
de la Monte SM; Tong M
J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
[TBL] [Abstract][Full Text] [Related]
6. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.
Grieb P
Mol Neurobiol; 2016 Apr; 53(3):1741-1752. PubMed ID: 25744568
[TBL] [Abstract][Full Text] [Related]
9. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology.
Akhtar A; Bishnoi M; Sah SP
Brain Res Bull; 2020 Nov; 164():83-97. PubMed ID: 32784004
[TBL] [Abstract][Full Text] [Related]
10. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
[TBL] [Abstract][Full Text] [Related]
11. Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin.
Lee Y; Kim YH; Park SJ; Huh JW; Kim SH; Kim SU; Kim JS; Jeong KJ; Lee KM; Hong Y; Lee SR; Chang KT
J Alzheimers Dis; 2014; 38(2):251-67. PubMed ID: 23948941
[TBL] [Abstract][Full Text] [Related]
12. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.
Freude S; Schilbach K; Schubert M
Curr Alzheimer Res; 2009 Jun; 6(3):213-23. PubMed ID: 19519303
[TBL] [Abstract][Full Text] [Related]
13. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
Moroz N; Tong M; Longato L; Xu H; de la Monte SM
J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
[TBL] [Abstract][Full Text] [Related]
14. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
15. T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.
Tong M; Deochand C; Didsbury J; de la Monte SM
J Alzheimers Dis; 2016; 51(1):123-38. PubMed ID: 26836193
[TBL] [Abstract][Full Text] [Related]
16. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
[TBL] [Abstract][Full Text] [Related]
17. si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder.
de la Monte SM; Tong M; Bowling N; Moskal P
Mol Brain; 2011 Mar; 4():13. PubMed ID: 21443795
[TBL] [Abstract][Full Text] [Related]
18. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model.
Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
Life Sci; 2017 Nov; 188():172-185. PubMed ID: 28867578
[TBL] [Abstract][Full Text] [Related]
19. Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
Liu P; Cui L; Liu B; Liu W; Hayashi T; Mizuno K; Hattori S; Ushiki-Kaku Y; Onodera S; Ikejima T
Physiol Behav; 2020 Jan; 213():112689. PubMed ID: 31669775
[TBL] [Abstract][Full Text] [Related]
20. Prenatal stress promotes icv-STZ-induced sporadic Alzheimer's pathology through central insulin signaling change.
Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
Life Sci; 2020 Jan; 241():117154. PubMed ID: 31857087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
